Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (91-100 of 224) with videos related to

Pageof 23
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2016
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registryAlessio La Manna, Alberto Chisari, Giuseppe Giacchi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 3, 2018
Pharmacokinetics of new oral anticoagulants: implications for use in routine careYlenia Ingrasciotta, Salvatore Crisafulli, Valeria Pizzimenti, et al.
International Journal of Cardiology|April 18, 2015
Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantationGiuseppe Gargiulo, Davide Capodanno, Anna Sannino, et al.
JACC. Cardiovascular Interventions|February 24, 2015
Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imagingYohei Ohno, Guilherme F Attizzani, Davide Capodanno, et al.
American Heart Journal|November 25, 2010
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesionsPiera Capranzano, Alessandra Sanfilippo, Francesco Tagliareni, et al.
JACC. Cardiovascular Interventions|November 24, 2022
P2Y<sub>12</sub> Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-AnalysisGiuseppe Andò, Giulia Azzurra De Santis, Antonio Greco, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 17, 2009
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION scoreDavide Capodanno, Piera Capranzano, Rita Bucalo, et al.
International Journal of Cardiology|November 16, 2017
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registryAlessio La Manna, Eligio Miccichè, Guido D'Agosta, et al.
The Journal of Invasive Cardiology|April 4, 2009
Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term resultsFrancesca Mirabella, Bruno Francaviglia, Davide Capodanno, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 13, 2010
Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registryRita Bucalo, Piera Capranzano, Giorgio Conti, et al.
Pageof 23

Showing results (91-100 of 224) with videos related to

Sort By:
Pageof 23
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2016
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registryAlessio La Manna, Alberto Chisari, Giuseppe Giacchi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 3, 2018
Pharmacokinetics of new oral anticoagulants: implications for use in routine careYlenia Ingrasciotta, Salvatore Crisafulli, Valeria Pizzimenti, et al.
International Journal of Cardiology|April 18, 2015
Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantationGiuseppe Gargiulo, Davide Capodanno, Anna Sannino, et al.
JACC. Cardiovascular Interventions|February 24, 2015
Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imagingYohei Ohno, Guilherme F Attizzani, Davide Capodanno, et al.
American Heart Journal|November 25, 2010
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesionsPiera Capranzano, Alessandra Sanfilippo, Francesco Tagliareni, et al.
JACC. Cardiovascular Interventions|November 24, 2022
P2Y<sub>12</sub> Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-AnalysisGiuseppe Andò, Giulia Azzurra De Santis, Antonio Greco, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 17, 2009
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION scoreDavide Capodanno, Piera Capranzano, Rita Bucalo, et al.
International Journal of Cardiology|November 16, 2017
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registryAlessio La Manna, Eligio Miccichè, Guido D'Agosta, et al.
The Journal of Invasive Cardiology|April 4, 2009
Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term resultsFrancesca Mirabella, Bruno Francaviglia, Davide Capodanno, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 13, 2010
Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registryRita Bucalo, Piera Capranzano, Giorgio Conti, et al.
Pageof 23